FAT1 and non-small cell lung carcinoma: Recently, Feng et al. discover that FAT family genes are potential prognostic and immunological biomarkers and correlate with response to ICIs in non-small cell lung cancer (50), demonstrating that FAT family may also play roles in STAD immunotherapy.